Effective and Affordable Flu Vaccines for the World

Informazioni relative al progetto

INDIGO

ID dell’accordo di sovvenzione: 874653

DOI 10.3030/874653

Data della firma CE 13 Dicembre 2019

Data di avvio 1 Aprile 2020

Data di completamento 31 Marzo 2025

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale € 16 000 968,00

Contributo UE € 9 975 979,00

Coordinato da

STICHTING AMSTERDAM UMC
Netherlands

Risultati finali

Documents, reports (2)

Report/Publication protective immunity TETRA-LITE in ferrets

ReportPublication protective immunity TETRALITE in ferrets

Report/Publication mode of action LVA for CTA

ReportPublication mode of action LVA for CTA

Websites, patent fillings, videos etc. (1)

Website, Facebook, etc.

Website Facebook etc

Pubblicazioni

Peer reviewed articles (2)

Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cells

Autori: Srinivasa Reddy Bonam, Peter Paul Platenburg and Jagadeesh Bayry
Pubblicato in: Frontiers Immunology, Numero 9 January 2023, 2023, ISSN 1664-3224
Editore: Frontiers in immunology

Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo

Autori: Sneha Raj, Preeti Vishwakarma, Shikha Saxena, Varun Kumar, Ritika Khatri, Amit Kumar, Mrityunjay Singh, Surbhi Mishra, Shailendra Asthana, Shubbir Ahmed andSweety Samal
Pubblicato in: Vaccines, Numero 31 March 2023, 2023, ISSN 2076-393X
Editore: Multidisciplinary Digital Publishing Institute (MDPI)